Hu Xiaolei, Jonzén Karolina, Lindahl Olof A, Karlsson Marcus, Norström Fredrik, Lundström Erik, Sunnerhagen Katharina Stibrant
Department of Community Medicine and Rehabilitation, Umeå University, Umeå, Sweden.
Department of Radiation Sciences, Radiation Physics, Biomedical Engineering, Umeå University, Umeå, Sweden.
JMIR Hum Factors. 2022 Jul 29;9(3):e38704. doi: 10.2196/38704.
Stroke is a leading cause of disability among adults, with heavy social and economic burden worldwide. A cost-effective solution is urgently needed to facilitate the identification of individual rehabilitation needs and thereby provide tailored rehabilitations to reduce disability among people who have had a stroke. A novel digital graphic follow-up tool Rehabkompassen has recently been developed to facilitate capturing the multidimensional rehabilitation needs of people who have had a stroke.
The aim of this study was to evaluate the feasibility and acceptability of conducting a definitive trial to evaluate Rehabkompassen as a digital follow-up tool among people who have had a stroke in outpatient clinical settings.
This pilot study of Rehabkompassen was a parallel, open-label, 2-arm prospective, proof-of-concept randomized controlled trial (RCT) with an allocation ratio of 1:1 in a single outpatient clinic. Patients who have had a stroke within the 3 previous months, aged ≥18 years, and living in the community were included. The trial compared usual outpatient visits with Rehabkompassen (intervention group) and without Rehabkompassen (control group) at the 3-month follow-up as well as usual outpatient visit with Rehabkompassen at the 12-month follow-up. Information on the recruitment rate, delivery, and uptake of Rehabkompassen; assessment and outcome measures completion rates; the frequency of withdrawals; the loss of follow-up; and satisfaction scores were obtained. The key outcomes were evaluated in both groups.
In total, 28 patients (14 control, 14 Rehabkompassen) participated in this study, with 100 patients screened. The overall recruitment rate was 28% (28/100). Retention in the trial was 86% (24/28) at the 12-month follow-up. All participants used the tool as planned during their follow-ups, which provided a 100% (24/24) task completion rate of using Rehabkompassen and suggested excellent feasibility. Both patient- and physician-participants reported satisfaction with the instrument (19/24, 79% and 2/2, 100%, respectively). In all, 2 (N=2, 100%) physicians and 18 (N=24, 75%) patients were willing to use the tool in the future. Furthermore, modified Rankin Scale as the primary outcome and various stroke impacts as secondary outcomes were both successfully collected and compared in this study.
This study demonstrated the high feasibility and adherence of the study protocol as well as the high acceptability of Rehabkompassen among patients who have had a stroke and physicians in an outpatient setting in comparison to the predefined criterion. The information collected in this feasibility study combined with the amendments of the study protocol may improve the future definitive RCT. The results of this trial support the feasibility and acceptability of conducting a large definitive RCT.
ClinicalTrials.gov NCT04915027; https://clinicaltrials.gov/ct2/show/NCT04915027.
中风是成年人残疾的主要原因,在全球范围内造成沉重的社会和经济负担。迫切需要一种具有成本效益的解决方案,以促进对个体康复需求的识别,从而提供量身定制的康复治疗,以减少中风患者的残疾。最近开发了一种新型数字图形随访工具Rehabkompassen,以促进了解中风患者的多维康复需求。
本研究的目的是评估在门诊临床环境中对中风患者进行一项确定性试验以评估Rehabkompassen作为数字随访工具的可行性和可接受性。
这项关于Rehabkompassen的试点研究是一项平行、开放标签、双臂前瞻性、概念验证随机对照试验(RCT),在单个门诊诊所中分配比例为1:1。纳入了在过去3个月内发生中风、年龄≥18岁且居住在社区的患者。该试验在3个月随访时比较了使用Rehabkompassen的常规门诊就诊(干预组)和不使用Rehabkompassen的常规门诊就诊(对照组),以及在12个月随访时使用Rehabkompassen的常规门诊就诊。获得了关于Rehabkompassen的招募率、交付和使用情况;评估和结局指标完成率;退出频率;失访情况;以及满意度得分的信息。在两组中评估了关键结局。
共有28名患者(14名对照组,14名Rehabkompassen组)参与了本研究,共筛选了100名患者。总体招募率为28%(28/100)。在12个月随访时,试验的保留率为86%(24/28)。所有参与者在随访期间都按计划使用了该工具,Rehabkompassen的任务完成率为100%(24/24),表明具有极佳的可行性。患者和医生参与者都对该工具表示满意(分别为19/24,79%和2/2,100%)。共有2名(N = 2,100%)医生和18名(N = 24,75%)患者愿意在未来使用该工具。此外,本研究成功收集并比较了作为主要结局的改良Rankin量表和作为次要结局的各种中风影响。
本研究证明了研究方案的高可行性和依从性,以及与预定义标准相比,Rehabkompassen在门诊环境中的中风患者和医生中具有较高的可接受性。本可行性研究中收集的信息与研究方案的修订相结合,可能会改善未来的确定性RCT。该试验的结果支持进行大型确定性RCT的可行性和可接受性。
ClinicalTrials.gov NCT04915027;https://clinicaltrials.gov/ct2/show/NCT04915027